1 ] Miyakis S, Lockshin MD, Atsumi T, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)[J]. J Thromb Haemost, 2006, 4(2): 295-306.
[2]
[ 2 ] Sciascia S, Murru V, Sanna G, et al. Clinical accuracy for diagnosis of antiphospholipid syndrome in systemic lupus erythematosus: evaluation of 23 possible combinations of antiphospholipid antibody specificities[J]. J Thromb Haemost, 2012, 10(12): 2512-2518.
[3]
[ 3 ] Wilson WA, Gharavi AE, Koike T, et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop[J]. Arthritis Rheum, 1999, 42(7): 1309- 1311.
[4]
[ 4 ] Hochberg MC. Updating the American college of rheumatology revised criteria for the classification of systemic lupus erythematosus[J]. Arthritis Rheum, 1997, 40(9): 1725.
[ 6 ] Cervera R, Piette JC, Font J, et al. Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients[J]. Arthritis Rheum, 2002, 46(4): 1019-1027.
[7]
[ 7 ] Kanakis MA, Kapsimali V, Vaiopoulos AG, et al. The lung in the spectrum of antiphospholipid syndrome[J]. Clin Exp Rheumatol, 2013, 31(3): 452-457.
[8]
[ 8 ] Espinosa G, Cervera R, Asherson RA, et al. The lung in the antiphospholipid syndrome[J]. Ann Rheum Dis, 2002, 61: 195-198.
[9]
[ 9 ] Zuily S, Huttin O, Mohamed S, et al. Valvular heart disease in antiphospholipid syndrome[J]. Curr Rheumatol Rep, 2013, 15(4): 320.
[10]
Mu？oz-Rodriguez FJ, Font J, Cervera R, et al. Clinical study and follow-up of 100 patients with the antiphospholipid syndrome[J]. Semin Arthritis Rheum, 1999, 29(3): 182-190.
[11]
Pengo V, Tripodi A, Reber G, et al. Update of the guidelines for lupus anticoagulant detection. Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis[J]. J Thromb Haemost, 2009, 7(10): 1737-1740.
[12]
Giannakopoulos B, Krilis SA. The pathogenesis of the antiphospholipid syndrome[J]. N Engl J Med, 2013, 368(11): 1033-1044.
[13]
Rosove MH, Brewer PM. Antiphospholipid thrombosis: clinical course after the first thrombotic event in 70 patients[J]. Ann Intern Med, 1992, 117(4): 303-308.
Galli M, Luciani D, Bertolini G, et al. Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature[J]. Blood, 2003, 101(5): 1827-1832.
[16]
Urbanus RT, Siegerink B, Roest M, et al. Antiphospholipid antibodies and risk of myocardial infarction and ischaemic stroke in young women in the RATIO study: a case-control study[J]. Lancet Neurol, 2009, 8(11): 998-1005.
[17]
Lockshin MD, Kim M, Laskin CA, et al. Prediction of adverse pregnancy outcome by the presence of lupus anticoagulant, but not anticardiolipin antibody, in patients with antiphospholipid antibodies[J]. Arthritis Rheum, 2012, 64(7): 2311-2318.
